デフォルト表紙
市場調査レポート
商品コード
1561636

ヒューマンエンハンスメント市場レポート:製品タイプ、エンドユーザー、地域別、2024年~2032年

Human Enhancement Market Report by Product (Exoskeleton, Smart Devices, Medical Devices, Implants, and Others), Device Type (Body Worn, Non-Body Worn), End User (Healthcare, Defense, Information Technology, and Others), and Region 2024-2032


出版日
発行
IMARC
ページ情報
英文 138 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
ヒューマンエンハンスメント市場レポート:製品タイプ、エンドユーザー、地域別、2024年~2032年
出版日: 2024年09月10日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のヒューマンエンハンスメントの市場の市場規模は2023年に1,117億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに3,272億米ドルに達し、2024年から2032年の間に12.1%の成長率(CAGR)を示すと予測しています。

ヒューマンエンハンスメントとは、個人の認知能力や身体能力、機能を高めるために、自然的、人工的、技術的に身体を変化させることを指します。これは、薬物、ホルモン、インプラント、遺伝子工学、栄養補助食品、美容整形手術などを用いて自己改善を図るものです。今日では、ヒューマンエンハンスメント技術の進歩により、マラリア、結核、ライム病などの病気に対する耐性が得られます。また、ヒト免疫不全ウイルス(HIV)感染を機能的に治療するためのクラスター化された規則的間隔を置いた短い回文反復(CRISPR)のようなゲノム編集技術においても、最新の診断や進歩を可能にしています。

ヒューマンエンハンスメントの市場動向:

急性および慢性疾患の蔓延は、ヘルスケア・サービスへのアクセスの増加と相まって、世界中のヒューマンエンハンスメント技術の需要にプラスの影響を与えている重要な要因の一つです。これらの技術には主にナノテクノロジー、情報技術(IT)、認知科学が含まれ、生物医学的介入の高度化や様々な疾患の診断・治療を支援します。また、人間の性能を超える特性を持つ義肢装具を作るのに役立つアクティブ・コントロール・システムも含まれます。さらに、遺伝子工学、神経細胞インプラント、ブレイン・コンピュータ・インターフェイス、3次元(3D)バイオプリンティングなどの新技術が市場の成長に寄与しています。これとは別に、国家間の地政学的緊張が高まっているため、いくつかの国の安全保障機関は、戦場でのパフォーマンスを向上させるための研究プログラムに投資しています。例えば、フランス陸軍の倫理委員会は、強化兵士を開発するためのヒューマンエンハンスメント技術の研究を承認しました。この調査には、薬物から外骨格に至るまで、標的決定において軍人を強化するための先進システムの利用も含まれます。これらの要因は、ヒューマンエンハンスメント技術の採用を促進し、今後数年間で市場にプラスの影響を与えると予想されます。

本レポートで扱う主な質問

  • 2023年の世界のヒューマンエンハンスメントの市場の市場規模は?
  • 2024年~2032年の世界のヒューマンエンハンスメントの市場の予想成長率は?
  • 世界のヒューマンエンハンスメントの市場に対するCOVID-19の影響は?
  • 世界のヒューマンエンハンスメントの市場を牽引する主要因は何か?
  • 世界のヒューマンエンハンスメントの市場の製品別内訳は?
  • ヒューマンエンハンスメントの市場の世界におけるデバイスタイプ別内訳は?
  • 世界のヒューマンエンハンスメントの市場のエンドユーザー別内訳は?
  • ヒューマンエンハンスメントの市場の世界における主要地域は?
  • 世界のヒューマンエンハンスメントの市場における主要プレイヤー/企業は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のヒューマンエンハンスメント市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:製品別

  • 外骨格
    • 市場動向
    • 市場予測
  • スマートデバイス
    • 市場動向
    • 市場予測
  • 医療機器
    • 市場動向
    • 市場予測
  • インプラント
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳:デバイスタイプ別

  • 身体装着
    • 市場動向
    • 市場予測
  • 非身体装着
    • 市場動向
    • 市場予測

第8章 市場内訳:エンドユーザー別

  • ヘルスケア
    • 市場動向
    • 市場予測
  • 防衛
    • 市場動向
    • 市場予測
  • 情報技術
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳:地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳:国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • BrainGate
    • B-Temia Inc
    • Ekso Bionics
    • Google LLC
    • Magic Leap Inc
    • Raytheon Technologies Corporation
    • ReWalk Robotics Ltd
    • Samsung Electronics Co. Ltd.
    • Second Sight Medical Products Inc.
    • Vuzix Corporation
図表

List of Figures

  • Figure 1: Global: Human Enhancement Market: Major Drivers and Challenges
  • Figure 2: Global: Human Enhancement Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Human Enhancement Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Human Enhancement Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Human Enhancement Market: Breakup by Device Type (in %), 2023
  • Figure 6: Global: Human Enhancement Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Human Enhancement Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Human Enhancement (Exoskeleton) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Human Enhancement (Exoskeleton) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Human Enhancement (Smart Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Human Enhancement (Smart Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Human Enhancement (Medical Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Human Enhancement (Medical Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Human Enhancement (Implants) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Human Enhancement (Implants) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Human Enhancement (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Human Enhancement (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Human Enhancement (Body Worn) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Human Enhancement (Body Worn) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Human Enhancement (Non-Body Worn) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Human Enhancement (Non-Body Worn) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Human Enhancement (Healthcare) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Human Enhancement (Healthcare) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Human Enhancement (Defense) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Human Enhancement (Defense) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Human Enhancement (Information Technology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Human Enhancement (Information Technology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Human Enhancement (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Human Enhancement (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: North America: Human Enhancement Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: North America: Human Enhancement Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: United States: Human Enhancement Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: United States: Human Enhancement Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Canada: Human Enhancement Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Canada: Human Enhancement Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Asia-Pacific: Human Enhancement Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Asia-Pacific: Human Enhancement Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: China: Human Enhancement Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: China: Human Enhancement Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Japan: Human Enhancement Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Japan: Human Enhancement Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: India: Human Enhancement Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: India: Human Enhancement Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: South Korea: Human Enhancement Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: South Korea: Human Enhancement Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Australia: Human Enhancement Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Australia: Human Enhancement Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Indonesia: Human Enhancement Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Indonesia: Human Enhancement Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Others: Human Enhancement Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Others: Human Enhancement Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Europe: Human Enhancement Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Europe: Human Enhancement Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Germany: Human Enhancement Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Germany: Human Enhancement Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: France: Human Enhancement Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: France: Human Enhancement Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: United Kingdom: Human Enhancement Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: United Kingdom: Human Enhancement Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Italy: Human Enhancement Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Italy: Human Enhancement Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Spain: Human Enhancement Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Spain: Human Enhancement Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Russia: Human Enhancement Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Russia: Human Enhancement Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Human Enhancement Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Human Enhancement Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Latin America: Human Enhancement Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Latin America: Human Enhancement Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Brazil: Human Enhancement Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Brazil: Human Enhancement Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Mexico: Human Enhancement Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Mexico: Human Enhancement Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Human Enhancement Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Human Enhancement Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Middle East and Africa: Human Enhancement Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Middle East and Africa: Human Enhancement Market: Breakup by Country (in %), 2023
  • Figure 78: Middle East and Africa: Human Enhancement Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Global: Human Enhancement Industry: SWOT Analysis
  • Figure 80: Global: Human Enhancement Industry: Value Chain Analysis
  • Figure 81: Global: Human Enhancement Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Human Enhancement Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Human Enhancement Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Human Enhancement Market Forecast: Breakup by Device Type (in Million US$), 2024-2032
  • Table 4: Global: Human Enhancement Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Human Enhancement Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Human Enhancement Market: Competitive Structure
  • Table 7: Global: Human Enhancement Market: Key Players
目次
Product Code: SR112024A4614

The global human enhancement market size reached US$ 111.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 327.2 Billion by 2032, exhibiting a growth rate (CAGR) of 12.1% during 2024-2032.

Human enhancement refers to a natural, artificial, and technological alteration of the body to enhance cognitive and physical capabilities and functions of individuals. It is undertaken using drugs, hormones, implants, genetic engineering to dietary supplements and cosmetic surgeries for self-improvement. Nowadays, advances in human enhancement technologies provide resistance against diseases like malaria, tuberculosis, and Lyme. They also allow up-to-date diagnostic and advancements in genome editing technologies, such as clustered regularly interspaced short palindromic repeats (CRISPR) for a functional cure of human immunodeficiency virus (HIV) infection.

Human Enhancement Market Trends:

The growing prevalence of acute and chronic diseases, in confluence with the increasing access to healthcare services, represents one of the key factors positively influencing the demand for human enhancement technologies around the world. These technologies mainly include nanotechnology, information technology (IT), and cognitive science, which assist in upgrading biomedical interventions as well as diagnose and treat various diseases. They also comprise active control systems that help create limb prosthetics with characteristics that exceed human performance. Moreover, emerging technologies like genetic engineering, neuronal implants, brain-computer interfaces, and three-dimensional (3D) bioprinting are contributing to the market growth. Apart from this, due to rising geopolitical tension between countries, security agencies of several countries are investing in research programs to improve battlefield performance. For instance, the ethics committee in the French Army approved the research of human enhancement technologies for developing enhanced soldiers. This research also involves the utilization of advanced systems, ranging from drugs to exoskeletons, to enhance military personnel in targeting decisions. These factors are anticipated to drive the adoption of human enhancement technologies and influence the market positively in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global human enhancement market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, device type, and end user.

Breakup by Product:

  • Exoskeleton
  • Smart Devices
  • Medical Devices
  • Implants
  • Others

Breakup by Device Type:

  • Body Worn
  • Non-Body Worn

Breakup by End User:

  • Healthcare
  • Defense
  • Information Technology
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being BrainGate, B-Temia Inc, Ekso Bionics, Google LLC, Magic Leap Inc, Raytheon Technologies Corporation, ReWalk Robotics Ltd, Samsung Electronics Co. Ltd., Second Sight Medical Products Inc. and Vuzix Corporation.

Key Questions Answered in This Report

  • 1. What was the size of the global human enhancement market in 2023?
  • 2. What is the expected growth rate of the global human enhancement market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global human enhancement market?
  • 4. What are the key factors driving the global human enhancement market?
  • 5. What is the breakup of the global human enhancement market based on the product?
  • 6. What is the breakup of the global human enhancement market based on the device type?
  • 7. What is the breakup of the global human enhancement market based on the end user?
  • 8. What are the key regions in the global human enhancement market?
  • 9. Who are the key players/companies in the global human enhancement market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Human Enhancement Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Exoskeleton
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Smart Devices
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Medical Devices
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Implants
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Device Type

  • 7.1 Body Worn
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Non-Body Worn
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Healthcare
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Defense
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Information Technology
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 BrainGate
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 B-Temia Inc
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Ekso Bionics
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Google LLC
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 SWOT Analysis
    • 14.3.5 Magic Leap Inc
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Raytheon Technologies Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 ReWalk Robotics Ltd
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Samsung Electronics Co. Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Second Sight Medical Products Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Vuzix Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials